NEW YORK (GenomeWeb News) – Verdezyne has received a $1.7 million grant from the National Institute of Allergy and Infectious Diseases that it will use to develop gene libraries for synthetic biology applications in its fermentation development program, the company said today.
The company, which formerly went by the name Coda Genomics, will use the Small Business Technology Transfer grant to fund development of bioinformatics applications for use in its mutant library and synthetic biology programs.
"By advancing this technology, we will be able to utilize the computational tools for improved protein expression and function for our internal biofuel and bio-based chemical programs," Verdezyne Chief Scientific Officer Stephen Picataggio said in a statement.
The firm said that the gene libraries platform it is developing will enhance current metabolic engineering tools.